These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 17690553
61. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Ann Neurol; 2004 Nov; 56(5):702-8. PubMed ID: 15449324 [Abstract] [Full Text] [Related]
62. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H. Cell Mol Neurobiol; 2006 Feb; 26(1):45-52. PubMed ID: 16633900 [Abstract] [Full Text] [Related]
63. [Cerebrospinal fluid neuron-specific enolase (NSE) and S-100b protein in Guillain-Barré syndrome--their relations to prognosis]. Mokuno K, Yasuda T, Sugimura K, Riku S, Takahashi A, Kato K. Rinsho Shinkeigaku; 1992 May; 32(5):535-7. PubMed ID: 1458733 [Abstract] [Full Text] [Related]
64. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Beaudry P, Cohen P, Brandel JP, Delasnerie-Lauprêtre N, Richard S, Launay JM, Laplanche JL. Dement Geriatr Cogn Disord; 1999 May; 10(1):40-6. PubMed ID: 10068257 [Abstract] [Full Text] [Related]
65. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M. Neurobiol Aging; 2009 Nov; 30(11):1834-41. PubMed ID: 18339451 [Abstract] [Full Text] [Related]
66. MRI sequence findings in sporadic Creutzfeldt-Jakob disease. Tian HJ, Zhang JT, Lang SY, Wang XQ. J Clin Neurosci; 2010 Nov; 17(11):1378-80. PubMed ID: 20727770 [Abstract] [Full Text] [Related]
67. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL. Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484 [Abstract] [Full Text] [Related]
69. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P. J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009 [Abstract] [Full Text] [Related]
70. Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: a diagnostic validity. Shiihara T, Miyake T, Izumi S, Watanabe M, Kamayachi K, Kodama K, Nabetani M, Ikemiyagi M, Yamaguchi Y, Sawaura N. Pediatr Int; 2012 Feb; 54(1):52-5. PubMed ID: 21883688 [Abstract] [Full Text] [Related]
71. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3. Llorens F, Villar-Piqué A, Hermann P, Schmitz M, Goebel S, Waniek K, Lachmann I, Zerr I. J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333 [Abstract] [Full Text] [Related]
72. [Analyses of 14-3-3 protein in the cerebrospinal fluid in Creutzfeldt-Jakob disease. Preliminary report]. Golańska E, Hułas-Bigoszewska K, Sikorska B, Liberski PP. Neurol Neurochir Pol; 2005 Feb; 39(5):358-65. PubMed ID: 16273459 [Abstract] [Full Text] [Related]
73. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease? Humpel C, Benke T. Pharmacology; 2017 Feb; 100(5-6):243-245. PubMed ID: 28743115 [Abstract] [Full Text] [Related]